Clinical Trials Directory

Trials / Completed

CompletedNCT00903448

Comparison of Prilosec Over-the-counter (OTC)® Versus Prevacid® for Gastric Acid Suppression

Comparison of Prilosec OTC® Versus Prevacid ® for Gastric Acid Suppression

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Procter and Gamble · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The objective of this study is to compare Prilosec OTC® to Prevacid® for gastric acid suppression.

Conditions

Interventions

TypeNameDescription
DRUGPrilosec OTC (omeprazole-magnesium)Prilosec OTC (omeprazole-magnesium 20.6 mg) tablet to be taken with a glass of water prior to breakfast
DRUGPrevacidPrevacid (15 mg lansoprazole) capsule to be taken with a glass of water prior to breakfast

Timeline

Start date
2009-04-01
Primary completion
2009-06-01
Completion
2009-06-01
First posted
2009-05-18
Last updated
2010-12-31
Results posted
2010-11-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00903448. Inclusion in this directory is not an endorsement.

Comparison of Prilosec Over-the-counter (OTC)® Versus Prevacid® for Gastric Acid Suppression (NCT00903448) · Clinical Trials Directory